0 items USD 0.00Search
- Did you mean
- psoriasis arthrex
Your search for "Psoriatic%20arthritis" gave back 2510 results.
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global Musculoskeletal Disorders Therapeutics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global Etoricoxib Intermediate market size was valued at US$ million in 2023. With growing demand in downstream market, the Etoricoxib...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Infliximab and Biosimilar market size was valued at US$ million in 2023. With growing demand in downstream market, the Infliximab and...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Arthritic Therapeutic market was valued at US$ 27240 million in 2023 and is anticipated to reach US$ 35210 million by 2030, witnessing a...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Etoricoxib is a non-steroidal anti-inflammatory drug (NSAID) that explicitly targets enzymes responsible for inflammation and pain namely...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Tumor necrosis factor inhibitor drug helps to stop physiologic response to tumor necrosis factor. The “Tumor Necrosis Factor Inhibitor Drug Industry...
Catalog:
LPI
February 2023
Price: USD 3,660.00
TNF Alpha Inhibitor are a group of medicines that suppress the body's natural response to tumor necrosis factor (TNF), a protein produced by...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Etoricoxib is a non-steroidal anti-inflammatory drug (NSAID) that explicitly targets enzymes responsible for inflammation and pain namely...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
COSENTYX (secukinumab), a prescription medication for treating moderate to severe plaque psoriasis, psoriatic arthritis, and ankylosing The global...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
The global Arthritic Therapeutic market size was valued at US$ 26650 million in 2023. With growing demand in downstream market, the Arthritic...
Catalog:
LPI
March 2024
Price: USD 3,660.00
A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Monoclonal antibodies are laboratory-produced substances that can locate and bind to specific molecules, such as tumor necrosis factor (TNF), a...
Catalog:
9Dimen Research
January 2021
Price: USD 2,850.00
Tumor necrosis factor inhibitor drug helps to stop physiologic response to tumor necrosis factor. The global Tumor Necrosis Factor Inhibitor Drug...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
